SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
赚大钱
Lv1
60 积分
2024-04-16 加入
最近求助
最近应助
互助留言
A multicenter, randomized phase II trial on the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors. 2023 European Congress of Internal Medicine, Abstract 2360
6天前
已关闭
A multicenter, randomized phase ii trial on the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors
11天前
已关闭
A retrospective case series assessing the efficacy and tolerability of romiplostim for the treatment of chemotherapy induced thrombocytopenia (CIT) in cancer patients: the UK experience
12天前
已关闭
9248 Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC)
12天前
已完结
9248 Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC)
12天前
已关闭
An open-label, dose-ranging study to assess the safety, efficacy, and pharmacokinetics of eltrombopag in treating thrombocytopenia in patients with advanced sarcomas receiving doxorubicin and ifosfamide
13天前
已关闭
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia
13天前
已完结
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
14天前
已完结
没有进行任何应助
不需要【积分已退回】
11天前
不需要【积分已退回】
12天前
发布错误【积分已退回】
12天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论